MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-20-0008212
Unique Biotech Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹198.58 Cr
▲ 16% YoY
Net profit · FY 2024
₹49.64 Cr
Net margin 25%
EBITDA · FY 2024
₹75.89 Cr
EBITDA margin 38.2%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹6 Cr
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹19.12 Cr
Company age
27 yrs
Est. 1999
Employees · EPFO
346
Provident fund records
About Unique Biotech Limited
Data last updated:
Unique Biotech Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 February 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1999PLC031113. Its GSTIN is 36AAACU4379H1Z3 (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹6 Cr. It was formerly known as Unique Biotech Private Limited. It is led by directors including Ratna Sudha Madempudi (Managing Director) and Jawahar Babu Medempudi (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹198.58 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹49.64 Cr (net margin 25%) and EBITDA of ₹75.89 Cr (EBITDA margin 38.2%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 19% over five years.
The company has about 346 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Unique Biotech. As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹19.12 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending. The company has 12 deals on record (9 secondary share transfers, 3 funding rounds), with disclosed funding of ₹4.43 Cr; the latest was in March 2014. Its 5 peer companies in the Pharma industry (Animal Pharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Astral Steritech Private Limited with revenue of ₹201.59 Cr.
Unique Biotech Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0008212). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website uniquebiotech.com.
Company Details of Unique Biotech Limited
CIN U24239TG1999PLC031113
Registration Number 031113
Incorporation Date 15 February 1999
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0008212
CIN History
Unique Biotech has one previous CIN (Corporate Identification Number): U24239AP1999PLC031113. The current CIN is U24239TG1999PLC031113, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1999PLC031113 | Current |
| U24239AP1999PLC031113 | Previous |
Key People
Ratna Sudha Madempudi Managing Director Jawahar Babu Medempudi Whole-Time Director Durga Prasad Vajjha Director Recognitions & Rankings of Unique Biotech
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No.2 Phase – II Genome Valley Kolthur Village, Shameerpet Mandal Medchal – Malkajgiri Dist, Hyderabad, Telangana, India – 500101
- IndustryPharma, Drug Formulation & Development, Animal Pharmaceuticals & Healthcare
Comprehensive company report
Unique Biotech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands
Unique Biotech operates one associated brand: Unique Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and supplies probiotic strains for food, supplements, and pharmaceutical sectors. | uniquebiotech.com |
Business Activity
The main business activity of Unique Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Unique Biotech Limited
FY 2024 filings availableUnique Biotech Limited reported revenue of ₹198.58 Cr (up 16% YoY) for FY 2024.
Revenue · FY 2024
₹198.58 Cr ▲ 16%
Net profit · FY 2024
₹49.64 Cr margin 25%
EBITDA · FY 2024
₹75.89 Cr margin 38.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 29%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 30%
5 years · compounded
▲ 28%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 16% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | ₹198.58 Cr | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹75.89 Cr | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹49.64 Cr | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 38.2% | |
| Net Profit Margin | 25% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2019-20 to FY 2022-23, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Unique Biotech are in the company report.
: available in the company report
Board of Directors and KMP of Unique Biotech Limited
Unique Biotech Limited currently reports 6 directors and 1 key managerial person. 4 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Durga Prasad Vajjha | Director | 01 Jan 2024 | 2 Years 9 Months | Current |
| Siva Kumar Ramaraju | Director | 01 Jul 2024 | 2 Years 3 Months | Current |
| Ratna Sudha Madempudi Also directs: Jeedimetla Effluent Treatment Limited. | Managing Director | 15 Feb 1999 | 27 Years 8 Months | Current |
| Krishna Teja Madempudi Also directs: Makers-Things India Private Limited | Director | 01 Jan 2024 | 2 Years 9 Months | Current |
| Manish Kumar Shukla Also directs: V&M Corporate Advisors LLP, Srivari Spices and Foods Limited, Healthy Investments Ltd and 3 more | Company Secretary | 27 May 2019 | 7 Years 4 Months | Current |
| Jawahar Babu Medempudi Also directs: Sleeper Hit Games LLP, RKR Estates LLP | Whole-Time Director | 01 Jan 2009 | 17 Years 9 Months | Current |
Showing 6 of 7 current directors and KMP. View all directors and KMP
Peer Comparison
Unique Biotech Limited is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Astral Steritech Private Limited | ₹201.59 Cr (FY 2022) | •••• | •••• | -36.0% | •••• | Vadodara, Gujarat, India |
| Synergia Life Sciences Private Limited | ₹201.39 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | Wada, Maharashtra, India |
| Precise Biopharma Private Limited | ₹200.73 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Mumbai, Maharashtra, India |
| Unique Biotech Limited this company | ₹198.58 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Hyderabad, Telangana, India |
| Alphamed Formulations Private Limited | ₹196.73 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Shamirpet, Telangana, India |
| Jagdale Industries Private Limited | ₹195.3 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Bangalore, Karnataka, India |
Peers are the companies nearest to Unique Biotech by revenue, above and below it, in the Pharma industry (Animal Pharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Unique Biotech Limited is audited by C K S Associates for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| C K S Associates | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Open charges
₹2 Cr
Satisfied charges
₹19.12 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2015 | Others | ₹2 Cr | Open |
| 15 Nov 2010 | Canara Bank | ₹2 Cr | Satisfied |
| 12 May 2009 | Kotak Mahindra Bank Limited | ₹30.61 Lakh | Satisfied |
| 09 Sep 2004 | Canara Bank | ₹14.46 Cr | Satisfied |
| 14 Jun 2003 | Canara Bank | ₹35 Lakh | Satisfied |
Total charge records: 8 View all charges
Deals & Funding
Unique Biotech Limited has 12 deals on record (9 secondary share transfers, 3 funding rounds), with disclosed funding of ₹4.43 Cr; the latest was in March 2014.
Total deals
12
Secondary share transfers
9
Funding rounds
3
Disclosed funding
₹4.43 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Hiranya Chem-Elec Equipment Pvt Ltd , Swain Finance and Trading Private Limited |
| Nov 2013 | Secondary share transfer | Undisclosed | Buyer: Amul B. Sanghani HUF, Rajesh B.Sanghani HUF, 2 individuals Seller: Gallery Exports Private Limited |
| Dec 2012 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Hiranya Chem-Elec Equipment Pvt Ltd |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: Gallery Exports Private Limited Seller: Unicorn Natural Products Private Limited |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Hiranya Chem-Elec Equipment Pvt Ltd |
: available in the company report
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases
Unique Biotech Limited has 2 court cases on record: 1 filed by Unique Biotech, 1 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
1
Filed against the company
1
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against Assistant Commissioner of State Tax and 4 Others and 4 others | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Unique Biotech Limited has a workforce of 346 employees as of Apr 09, 2024.
Employee count
346
Active EPFO establishments
1
Employee growth
14.57%
: available in the company report
Recent Activity
Unique Biotech Limited has 11 board changes on record since 1999: 7 appointments and 4 cessations. The latest: Siva Kumar Ramaraju was appointed as Director on 01 Jul 2024.
Charges
A charge with Others of Rs. 2.00 Cr registered on 23 Jun 2015 with Charge ID 10580985 was modified on 27 Oct 2025.
AGM
Unique Biotech Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Siva Kumar Ramaraju was appointed as Director.
Filing
Unique Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Durga Prasad Vajjha was appointed as Director.
Appointed
Krishna Teja Madempudi was appointed as Director.
Ceased
Jawahar Babu Medempudi ceased to be Director.
Appointed
Manish Kumar Shukla was appointed as Company Secretary.
Charges
A charge registered on 09 Sep 2004 via Charge ID 90128665 with Canara Bank was fully satisfied on 17 Jul 2015.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 10580985 was registered on 23 Jun 2015.
Ceased
Ravikumar Medampudi ceased to be Director.
Ceased
Venkateswara Rao Ravella ceased to be Director.
20 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Unique Biotech has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACU4379H1Z3 | Telangana | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Related news
Frequently Asked Questions
Unique Biotech is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 February 1999 (27+ years old) and is registered under CIN U24239TG1999PLC031113.
Unique Biotech has 7 current directors and KMP:
- Ratna Sudha Madempudi - Managing Director
- Jawahar Babu Medempudi - Whole-Time Director
- Durga Prasad Vajjha - Director
- Siva Kumar Ramaraju - Director
- Krishna Teja Madempudi - Director
- Venkata Satya Kumar Chakravarthy Ravella - Director
- Manish Kumar Shukla - Company Secretary
The latest financial statements of Unique Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Unique Biotech is 36AAACU4379H1Z3, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Unique Biotech is U24239TG1999PLC031113. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unique Biotech has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.
Unique Biotech was incorporated on 15 February 1999, making it 27+ years old. It is registered with the Registrar of Companies, Hyderabad.
Unique Biotech has 12 deals on record (9 secondary share transfers, 3 funding rounds), with disclosed funding of ₹4.43 Cr; the latest was in March 2014.
The peers of Unique Biotech by revenue are Astral Steritech Private Limited, Synergia Life Sciences Private Limited, Precise Biopharma Private Limited, Alphamed Formulations Private Limited, Jagdale Industries Private Limited, all in the Pharma industry (Animal Pharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Siva Kumar Ramaraju was appointed as Director on 01 Jul 2024. Durga Prasad Vajjha was appointed as Director on 01 Jan 2024. Krishna Teja Madempudi was appointed as Director on 01 Jan 2024. Unique Biotech has 11 board changes on record in total.
Yes, Unique Biotech is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-20-0008212).